Skip to main content

HIPRA participated at SEPOR 2020 pointing out the benefits of intradermal vaccination


HIPRA has participated as sponsor at the 53rd edition of SEPOR 2020 (Spanish livestock, industrial and food fair) which this year, due the COVID-19 situation, has been online.


On this occasion, HIPRA had a virtual premium stand where it showed it newest products, for example its newest vaccine: MHYOSPHERE® PCV ID, the first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one.

HIPRA also participated in the conferences cycle with the presentation titled “New vaccination strategies to improve farm management and animal welfare”, led by Daniel Torrents, Head of Technical Services for Swine at HIPRA Spain.


Torrents showed how we can improve management on farms and animal welfare using ready-to-use vaccines through different ways of vaccination instead of the traditional ones.

At the conference, HIPRA presented its new intradermal vaccination device Hipradermic® 3.0 and MHYOSPHERE® PCV ID vaccine as referents in new systems of vaccination and new ready-to-use vaccines.


With its participation at SEPOR 2020, HIPRA reinforces its commitment to prevention in animal health, especially during the current COVID-19 situation.